Evidence map›Paper›PMID 38756512›Full record

ArticleFrontiers in veterinary science2024

Oxytocin, prostaglandin F2

Alice Carbonari, Matteo Burgio, Lorenza Frattina, Edmondo Ceci, Maurizio Sciannamblo, Pasquale Ricci, Vincenzo Cicirelli, Annalisa Rizzo

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alice CarbonariDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Matteo BurgioDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Lorenza FrattinaDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Edmondo CeciDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Maurizio SciannambloDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Pasquale RicciDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Vincenzo CicirelliDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.
Annalisa RizzoDepartment of Veterinary Medicine, University of Bari Aldo Moro, Valenzano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to compare the effect of three substances with ecbolic activity, Oxytocin, Prostaglandin F2α (PGF2α) and Scopolamine, on the uterine involution process in dairy cows and on the resumption of ovarian activity. Eighty bovine were randomly divided in four groups: GROUP C: 20 cows treated, within 24 h of calving, with 5 mL/head of saline solution; GROUP PG: 20 cows treated, within 24 h of calving, with 150 μg/head of d-cloprostenol; GROUP OX: 20 cows treated, within 24 h of calving, with 50 IU/head of oxytocin acetate; GROUP S: 20 cows treated, within 24 h of calving, with 40 mg/q Scopolamine Butylbromide. Each cow was subjected to blood samples to evaluate the Hydroxyproline (HYP) levels, at T0, within 24 h after calving, and T7, T14, T28, 7, 14, and 28 days after calving, respectively. At T14 and T28, an ultrasound examination was performed to measure the diameter of ex-pregnant horn. In all cows, the reproductive indices (days to first service and number of artificial insemination for conception) were evaluated. In all groups, the HYP concentrations have been rising from T0 to T28, with the maximum levels obtained at T28 in the groups PG and S. As regard the diameter of uterine horn, the comparison among the groups showed significant differences only at T28, with lower values in the group PG and S. In group S and PG, the days to first service were less than other groups. Treatment with Scopolamine and PGF2α resulted in better outcomes, evidenced clinically by more efficient uterine involution and faster ovarian recovery.

Indexed as

bovineoxytocinprostaglandin F2αscopolamineuterine involution

Identifiers

PMID38756512
PMCPMC11096567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.